ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1910

Evaluation of Dynamic Effects of Depressive Symptoms on Functional Outcomes in Knee Osteoarthritis

Rhea Mehta1, Marc Hochberg2, Michelle Shardell1, Alice Ryan1, Yu Dong1, Brock Beamer1, Jason Peer2, Megan Schuler3, Joseph Gallo4, Elizabeth Stuart4 and Alan Rathbun1, 1University of Maryland, School of Medicine, Baltimore, MD, 2University of Maryland School of Medicine, Baltimore, MD, 3Rand Inc., Boston, MA, 4Johns Hopkins Bloomberg School of Public Health, Baltimore, MD

Meeting: ACR Convergence 2022

Keywords: depression, functional status, gait, Osteoarthritis, physical activity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2022

Title: Osteoarthritis – Clinical Poster

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: Knee OA is a leading cause of functional decline, and psychiatric comorbidity is common, particularly major depression. Depressive symptoms decrease physical activity and exacerbate functional disability, but depression is dynamic, and research has not assessed how these fluctuations affect functional outcomes as knee OA progresses. The study objective was to evaluate how changes in depressive symptoms affect functional outcomes among persons with radiographic knee OA (Figure 1).

Methods: Participants (n=2,212) from the Osteoarthritis Initiative (N=4,796) with radiographic knee OA (Kellgren-Lawrence grade ≥ 2 in one or both knees) and complete baseline data were included in the analytic sample. Depressive symptoms were assessed as a time-varying score using the Center for Epidemiological Studies Depression Scale (CES-D; range 0-60) at baseline and first three annual follow-up visits. Functional outcomes were measured at the first four annual follow-up visits and included gait speed and Physical Activity Scale for the Elderly (PASE). Outcome variables were standardized such that associations could be interpreted as differences in standard deviations per unit CES-D. Time-invariant confounders were measured at study enrollment and included demographic, socioeconomic, and lifestyle factors. Time-varying covariates were measured concurrent to CES-D scores and included BMI, pain, additional treatments, and other knee OA signs and symptoms. The primary method of analysis was marginal structural models that estimated main and time-specific effects of depressive symptoms on functional outcomes.

Results: There were significant main effects (Table 1) of depressive symptoms on both gait speed (β = -0.0045; 95% CI: -0.0080, -0.0011) and PASE (β = -0.0053; 95% CI: -0.0094, -0.0011) that indicated physical performance and physical activity were lower with higher CES-D scores. However, there was variability regarding the effects of depressive symptoms on functional outcomes (Figure 2) as evidenced by exposure-by-time interactions for the first to fourth follow-up interval for gait speed (P = 0.018) and first to second follow-up interval for PASE (P=0.055). The influence of depressive symptoms on gait speed declined over time from the first (β = -0.0079; 95% CI: -0.0125, -0.0032) to fourth (β = -0.0012; 95% CI: -0.0061, 0.0037) follow-up interval. Similarly, the association between depressive symptoms and PASE decreased from the first (β = -0.0086; 95% CI: -0.0141, -0.0030) to second (β = -0.0012; 95% CI: -0.0079, 0.0055) follow-up interval but then exhibited a reversion during the third and fourth follow-up intervals.

Conclusion: These findings imply that the negative effect of depressive symptoms on functional outcomes in knee OA decreases over time as structural and clinical knee OA progresses. Nonetheless, the significant effect of depressive symptoms on functional outcomes, particularly earlier in time, highlights the need for early intervention on comorbid depression in knee OA patients to prevent functional declines and maintain physical performance and activity during aging.

Supporting image 1

Supporting image 2

Figure 1. Directed Acyclic Graph Depicting the Epidemiological Study Design and Hypothesized Causal Relationships Between Depressive Symptoms, Functional Outcomes, Time-Invariant and Time-Varying Confounders

Supporting image 3

Figure 2. Average Marginal Effects of Time-Varying CES-D Scores on Standardized A) Gait Speed and B) PASE. CESD: Center for Epidemiological Studies Scale; PASE: Physical Activity Scale for the Elderly


Disclosures: R. Mehta, None; M. Hochberg, None; M. Shardell, None; A. Ryan, None; Y. Dong, None; B. Beamer, None; J. Peer, None; M. Schuler, None; J. Gallo, None; E. Stuart, None; A. Rathbun, None.

To cite this abstract in AMA style:

Mehta R, Hochberg M, Shardell M, Ryan A, Dong Y, Beamer B, Peer J, Schuler M, Gallo J, Stuart E, Rathbun A. Evaluation of Dynamic Effects of Depressive Symptoms on Functional Outcomes in Knee Osteoarthritis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/evaluation-of-dynamic-effects-of-depressive-symptoms-on-functional-outcomes-in-knee-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluation-of-dynamic-effects-of-depressive-symptoms-on-functional-outcomes-in-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology